In the present work, we investigated the effect of a vaccine combined with 4-1BBL-expressing tumor vaccine and CTLA-4 blockade on the survival of C57BL/6 mice transplanted subcutaneously with prostate cancer RM-1 cells. The gene discussed is CTLA4; the disease is neoplasm.